Search
Maroxepin
go.drugbank.com/drugs/DB21379ExperimentalMaroxepin is a small molecule drug. The usage of the INN stem '-oxepin' in the name indicates that Maroxepin is a tricyclic compound. Maroxepin has a monoisotopic molecular weight of 277.15 Da.
Reclazepam
go.drugbank.com/drugs/DB21411ExperimentalReclazepam is a small molecule drug. The usage of the INN stem '-azepam' in the name indicates that Reclazepam is a diazepam derivative. Reclazepam has a monoisotopic molecular weight of 373.04 Da.
Metoxepin
go.drugbank.com/drugs/DB21433ExperimentalMetoxepin is a small molecule drug. The usage of the INN stem '-oxepin' in the name indicates that Metoxepin is a tricyclic compound. Metoxepin has a monoisotopic molecular weight of 322.17 Da.
Rizedisben
go.drugbank.com/drugs/DB21610InvestigationalRizedisben is a small molecule drug. Rizedisben is under investigation in clinical trial NCT04983862 (Fluorescent Imaging of Nerves with Illuminare-1 During Surgery). … Rizedisben has a monoisotopic molecular weight of 519.22 Da.
Davelizomib
go.drugbank.com/drugs/DB21660ExperimentalDavelizomib is a small molecule drug. The usage of the INN stem '-zomib' in the name indicates that Davelizomib is a proteasome inhibitor. Davelizomib has a monoisotopic molecular weight of 481.18 Da.
Haloprogin
go.drugbank.com/drugs/DB00793ApprovedWithdrawnHaloprogin is used as a topical ointment or cream in the treatment of Tinea infections. … Haloprogin is no longer available in the United States and has been discontinued.
Perhexiline
go.drugbank.com/drugs/DB01074ApprovedPerhexiline is a coronary vasodilator used especially for angina of effort. It may cause neuropathy and hepatitis.
IL15-NK Cell
go.drugbank.com/drugs/DB15725InvestigationalIn particular, incubation with IL-15 allows NK cells to lyse a broad range of fresh and cultured tumor targets that the cell is not normally sensitive to.
Idetrexed
go.drugbank.com/drugs/DB21469InvestigationalIdetrexed is a small molecule drug. The usage of the INN stem '-trexed' in the name indicates that Idetrexed is a antineoplastic; thymidilate synthetase inhibitor. … Idetrexed is under investigation in clinical trial NCT02360345 (Phase I Trial of ONX-0801 Once Weekly or Alternate Weekly). Idetrexed has a monoisotopic molecular weight of 647.22 Da.